2024-09-012025-08-312025-08-31false12824276NEWCASTLE GYNAECOLOGY CLINIC LTD2025-12-0886220falseiso4217:GBPxbrli:pure128242762024-08-31128242762025-08-31128242762024-09-012025-08-31128242762023-08-31128242762024-08-31128242762023-09-012024-08-3112824276bus:SmallEntities2024-09-012025-08-3112824276bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3112824276bus:AbridgedAccounts2024-09-012025-08-3112824276bus:PrivateLimitedCompanyLtd2024-09-012025-08-3112824276core:WithinOneYear2025-08-3112824276core:AfterOneYear2025-08-3112824276core:WithinOneYear2024-08-3112824276core:AfterOneYear2024-08-3112824276core:ShareCapital2025-08-3112824276core:SharePremium2025-08-3112824276core:RevaluationReserve2025-08-3112824276core:OtherReservesSubtotal2025-08-3112824276core:RetainedEarningsAccumulatedLosses2025-08-3112824276core:ShareCapital2024-08-3112824276core:SharePremium2024-08-3112824276core:RevaluationReserve2024-08-3112824276core:OtherReservesSubtotal2024-08-3112824276core:RetainedEarningsAccumulatedLosses2024-08-3112824276core:LandBuildings2025-08-3112824276core:PlantMachinery2025-08-3112824276core:Vehicles2025-08-3112824276core:FurnitureFittings2025-08-3112824276core:OfficeEquipment2025-08-3112824276core:NetGoodwill2025-08-3112824276core:IntangibleAssetsOtherThanGoodwill2025-08-3112824276core:ListedExchangeTraded2025-08-3112824276core:UnlistedNon-exchangeTraded2025-08-3112824276core:LandBuildings2024-08-3112824276core:PlantMachinery2024-08-3112824276core:Vehicles2024-08-3112824276core:FurnitureFittings2024-08-3112824276core:OfficeEquipment2024-08-3112824276core:NetGoodwill2024-08-3112824276core:IntangibleAssetsOtherThanGoodwill2024-08-3112824276core:ListedExchangeTraded2024-08-3112824276core:UnlistedNon-exchangeTraded2024-08-3112824276core:LandBuildings2024-09-012025-08-3112824276core:PlantMachinery2024-09-012025-08-3112824276core:Vehicles2024-09-012025-08-3112824276core:FurnitureFittings2024-09-012025-08-3112824276core:OfficeEquipment2024-09-012025-08-3112824276core:NetGoodwill2024-09-012025-08-3112824276core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3112824276core:ListedExchangeTraded2024-09-012025-08-3112824276core:UnlistedNon-exchangeTraded2024-09-012025-08-3112824276core:MoreThanFiveYears2024-09-012025-08-3112824276core:Non-currentFinancialInstruments2025-08-3112824276core:Non-currentFinancialInstruments2024-08-3112824276dpl:CostSales2024-09-012025-08-3112824276dpl:DistributionCosts2024-09-012025-08-3112824276core:LandBuildings2024-09-012025-08-3112824276core:PlantMachinery2024-09-012025-08-3112824276core:Vehicles2024-09-012025-08-3112824276core:FurnitureFittings2024-09-012025-08-3112824276core:OfficeEquipment2024-09-012025-08-3112824276dpl:AdministrativeExpenses2024-09-012025-08-3112824276core:NetGoodwill2024-09-012025-08-3112824276core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3112824276dpl:GroupUndertakings2024-09-012025-08-3112824276dpl:ParticipatingInterests2024-09-012025-08-3112824276dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3112824276core:ListedExchangeTraded2024-09-012025-08-3112824276dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3112824276core:UnlistedNon-exchangeTraded2024-09-012025-08-3112824276dpl:CostSales2023-09-012024-08-3112824276dpl:DistributionCosts2023-09-012024-08-3112824276core:LandBuildings2023-09-012024-08-3112824276core:PlantMachinery2023-09-012024-08-3112824276core:Vehicles2023-09-012024-08-3112824276core:FurnitureFittings2023-09-012024-08-3112824276core:OfficeEquipment2023-09-012024-08-3112824276dpl:AdministrativeExpenses2023-09-012024-08-3112824276core:NetGoodwill2023-09-012024-08-3112824276core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3112824276dpl:GroupUndertakings2023-09-012024-08-3112824276dpl:ParticipatingInterests2023-09-012024-08-3112824276dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3112824276core:ListedExchangeTraded2023-09-012024-08-3112824276dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3112824276core:UnlistedNon-exchangeTraded2023-09-012024-08-3112824276core:NetGoodwill2025-08-3112824276core:IntangibleAssetsOtherThanGoodwill2025-08-3112824276core:LandBuildings2025-08-3112824276core:PlantMachinery2025-08-3112824276core:Vehicles2025-08-3112824276core:FurnitureFittings2025-08-3112824276core:OfficeEquipment2025-08-3112824276core:AfterOneYear2025-08-3112824276core:WithinOneYear2025-08-3112824276core:ListedExchangeTraded2025-08-3112824276core:UnlistedNon-exchangeTraded2025-08-3112824276core:ShareCapital2025-08-3112824276core:SharePremium2025-08-3112824276core:RevaluationReserve2025-08-3112824276core:OtherReservesSubtotal2025-08-3112824276core:RetainedEarningsAccumulatedLosses2025-08-3112824276core:NetGoodwill2024-08-3112824276core:IntangibleAssetsOtherThanGoodwill2024-08-3112824276core:LandBuildings2024-08-3112824276core:PlantMachinery2024-08-3112824276core:Vehicles2024-08-3112824276core:FurnitureFittings2024-08-3112824276core:OfficeEquipment2024-08-3112824276core:AfterOneYear2024-08-3112824276core:WithinOneYear2024-08-3112824276core:ListedExchangeTraded2024-08-3112824276core:UnlistedNon-exchangeTraded2024-08-3112824276core:ShareCapital2024-08-3112824276core:SharePremium2024-08-3112824276core:RevaluationReserve2024-08-3112824276core:OtherReservesSubtotal2024-08-3112824276core:RetainedEarningsAccumulatedLosses2024-08-3112824276core:NetGoodwill2023-08-3112824276core:IntangibleAssetsOtherThanGoodwill2023-08-3112824276core:LandBuildings2023-08-3112824276core:PlantMachinery2023-08-3112824276core:Vehicles2023-08-3112824276core:FurnitureFittings2023-08-3112824276core:OfficeEquipment2023-08-3112824276core:AfterOneYear2023-08-3112824276core:WithinOneYear2023-08-3112824276core:ListedExchangeTraded2023-08-3112824276core:UnlistedNon-exchangeTraded2023-08-3112824276core:ShareCapital2023-08-3112824276core:SharePremium2023-08-3112824276core:RevaluationReserve2023-08-3112824276core:OtherReservesSubtotal2023-08-3112824276core:RetainedEarningsAccumulatedLosses2023-08-3112824276core:AfterOneYear2024-09-012025-08-3112824276core:WithinOneYear2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3112824276core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3112824276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3112824276core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3112824276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3112824276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3112824276bus:Director12024-09-012025-08-31

NEWCASTLE GYNAECOLOGY CLINIC LTD

Registered Number
12824276
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

NEWCASTLE GYNAECOLOGY CLINIC LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director

RATNAVELU, Nithya, Dr

Registered Address

15 Riverside Studios Amethyst Road
Newcastle Business Park
Newcastle Upon Tyne
NE4 7YL

Registered Number

12824276 (England and Wales)
NEWCASTLE GYNAECOLOGY CLINIC LTD
Statement of Financial Position
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3513857
513857
Current assets
Debtors14,836-
Cash at bank and on hand5,04616,954
19,88216,954
Creditors amounts falling due within one year(7,080)(5,570)
Net current assets (liabilities)12,80211,384
Total assets less current liabilities13,31512,241
Creditors amounts falling due after one year(8,463)(7,811)
Net assets4,8524,430
Capital and reserves
Called up share capital22
Profit and loss account4,8504,428
Shareholders' funds4,8524,430
The financial statements were approved and authorised for issue by the Director on 8 December 2025, and are signed on its behalf by:
RATNAVELU, Nithya, Dr
Director
Registered Company No. 12824276
NEWCASTLE GYNAECOLOGY CLINIC LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

20252024
Average number of employees during the year00
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 September 242,346
At 31 August 252,346
Depreciation and impairment
At 01 September 241,489
Charge for year344
At 31 August 251,833
Net book value
At 31 August 25513
At 31 August 24857